sebetralstat: Clinical Trials

4 trials of sebetralstat, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

4 completed. 4 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	4	Completed 4

Follow sebetralstat: new trials by email Literature Review of sebetralstat trials Research Report on sebetralstat

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II KVD900 150 mg, KVD900 300 mg, KVD900 600 mg - Hereditary Angioedema	Phase 3	Completed	KalVista Pharmaceuticals, Ltd.	36	2024-08-01	2026-08-05
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE) KVD900 600 mg, KVD900 300 mg - Hereditary Angioedema	Phase 3	Completed	KalVista Pharmaceuticals, Ltd.	145	2022-10-24	2026-06-05
PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial KVD900 600 mg, Drug: KVD900 300 mg - Hereditary Angioedema	Phase 3	Completed	KalVista Pharmaceuticals, Ltd.	11	2022-10-24	2026-06-08
A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE) Placebo, KVD900 600 mg, KVD900 300 mg - Hereditary Angioedema	Phase 3	Completed	KalVista Pharmaceuticals, Ltd.	136	2022-02-22	2025-05-02

Conditions studied

Sponsors

Countries

Results publications